DSM Sinochem Pharmaceuticals successfully launches Rosuvastatin finished dosage formulation in Western Europe
Rijswijk, Netherlands, Jan. 12, 2018 (GLOBE NEWSWIRE) -- Upon patent expiry at the end of December 2017, DSM Sinochem Pharmaceutical (DSP) has successfully launched its fully backward integrated, generic Rosuvastatin drug product in multiple Western European countries. The successful launch will be extended to additional countries prior to the end of January, among which is the Netherlands.
After being one of the first companies globally to receive a CEP in early 2016 for Rosuvastatin API, DSP again proves to be a frontrunner by being one of the first to launch Rosuvastatin drug products in Western Europe using its in-house produced API.
Statins are currently the most prescribed drug class globally for high cholesterol and cardiovascular diseases and are among the top selling drugs worldwide. Rosuvastatin is used for reducing high cholesterol and preventing cardiovascular disease, which is the number one cause of death worldwide.
Quality, Reliability and Sustainability
In line with its brand promise of Quality, Reliability and Sustainability, DSP's Rosuvastatin offers customers superior performance in all three areas. For its finished dosage formulations, DSP uses its own in-house manufactured API. This proprietary, backward integrated, process, which is protected by 10 patent families, involves a highly efficient enzymatic coupling step, and offers customers independence from third party intermediate suppliers. Additional advantages to its API include unrivalled product quality with an assay of >99% and large batch sizes of 200 kg. This further results in significantly reduced Quality Assurance and testing costs, the absence of hazardous residual chemicals and a 35% reduced carbon footprint related to production.
With the successful launch of the Rosuvastatin finished dosage formulation, on top of the earlier successful launch of DSP's beta lactam drug products, and the upcoming launch of Atorvastatin in Europe by summer 2018, the company is quickly expanding its drug product portfolio. What sets DSP apart from competitors is its backward integration and full control of its supply chain.
CEO, Karl Rotthier: "I am proud that our company, together with our partners, is among the first worldwide to launch a generic Rosuvastatin finished dosage formulation in Western Europe upon patent expiration; after being one of the first to offer the Rosuvastatin API under CEP. This shows our dedication to excellence and our aspiration to continue to be an industry leader".
BU Director Drug Products, Lucas Wiarda: "As with every one of our products, Rosuvastatin delivers superior performance on quality, reliability and sustainability compared to the industry average. This is largely due to DSP's full control of its manufacturing process from start to finish. Building on our strong position in beta lactams, Rosuvastatin is an excellent addition to our drug products portfolio which we proudly offer to our customers."
Currently DSP holds an eCTD dossier for Rosuvastatin finished dosage formulations (5,10,20 & 40mg FCT) containing Zone II & IV stability data and a 36 month shelf life.
About DSM Sinochem Pharmaceuticals
DSM Sinochem Pharmaceuticals (DSP) is the global leader in sustainable antibiotics, next-generation statins and anti-fungals. DSP develops, produces and sells intermediates, active pharmaceutical ingredients and drug products. Our employees worldwide work together to deliver cutting-edge generics solutions that help to keep customers ahead of the competition.
Headquartered in Singapore, the group has manufacturing sites and sales offices in China, India, Egypt, the Netherlands, Spain, the USA and Mexico. DSP is a 50/50 Joint Venture of Royal DSM, a global science-based company active in health, nutrition and materials, and Sinochem Group, a Fortune 500 enterprise.
For more information please visit www.dsm-sinochem.com or contact DSM Sinochem Pharmaceuticals Corporate Communications, Erin van Wijngaarden, Manager PR & Corporate Communications. E-Mail: firstname.lastname@example.org
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/7ac00118-d5bc-405d-a32d-b02d5c584c11
Erin van Wijngaarden DSM Sinochem Pharmaceuticals email@example.com
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: DSM Sinochem Pharmaceuticals via Globenewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Følg saker fra GlobeNewswire
Registrer deg med din epostadresse under for å få de nyeste sakene fra GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra GlobeNewswire
Cloudian Provides Seamless Hybrid and Multi-cloud Storage Integration for Veeam Environments22.1.2019 20:05 | Pressemelding
Object Storage Platform Delivers Highly Cost-effective, Exabyte-scalable Backup, Archive and Disaster Recovery Under Single Data Management Architecture SAN MATEO, Calif., Jan. 22, 2019 (GLOBE NEWSWIRE) -- Cloudian today announced that its HyperStore object storage platform integrates seamlessly with Veeam’s newest data protection software release, Veeam Availability Suite 9.5 Update 4. This integration provides new and existing Veeam customers with highly cost-effective, limitlessly scalable storage that works across public and private cloud environments. With data playing an increasingly central role in an organization’s success, keeping it safe and readily available is more critical than ever. However, doing so has become more challenging in the face of continued rapid data growth. Veeam software is designed to provide both data protection and availability for all workloads—physical, virtual and cloud—and one of the key features in the new release is support of S3-compatible object
Brookfield Asset Management Notice of 2018 Year End Results Conference Call and Webcast22.1.2019 15:37 | Pressemelding
Date: Thursday, February 14, 2019 Time: 11:00 a.m. (Eastern Time) BROOKFIELD, NEWS, Jan. 22, 2019 (GLOBE NEWSWIRE) -- Brookfield Asset Management (NYSE:BAM)(TSX:BAM.A)(EURONEXT AMSTERDAM:BAMA): You are invited to participate in Brookfield Asset Management’s 2018 Year End Results Conference Call & Webcast on Thursday, February 14, 2019 at 11:00 a.m. (Eastern Time) to discuss with members of senior management our results and current business initiatives. These results will be released on February 14th before 7:00 a.m. (Eastern Time) and will be available following the release on our website at www.brookfield.com “News – Press Releases.” The Conference Call will also be Webcast live on our website, where it will be archived for future reference. To participate in the Conference Call, please dial 1-866-688-9425 toll free in North America, or for overseas calls please dial 1-409-216-0815 (Conference ID: 7174879) at approximately 10:50 a.m. The Conference Call will also be Webcast live at ht
K2 Acquires Distributor K2NE, Strengthening Its Digital Process Automation Capabilities Across Europe22.1.2019 15:00 | Pressemelding
Acquisition expands the digital process automation company’s presence into new markets Bellevue, Wash., Jan. 22, 2019 (GLOBE NEWSWIRE) -- SourceCode Technology Holdings, Inc. (“K2”), the leader in low-code digital process automation, today announced the acquisition of one of its distributors, K2NE. With this acquisition, K2 establishes a direct presence in mainland Europe, increasing the direct customer footprint to 14 European countries, further investing and committing to growth across the continent. K2 customers will now see increased opportunities and offerings centered around strengthening their digital transformation. K2NE has a demonstrated history of strong business growth and success gaining market shares in Spain, Switzerland and Germany. “We are thrilled to welcome the K2NE team to the K2 family,” said Evan Ellis, K2 CEO. “As two organizations built around customer-first approaches to digital process automation, we can together leverage our common vision, expand our geograph
Altus Group Report Reveals Rapid Acceleration of PropTech Adoption and Rise of Disintermediation as Major Trends Impacting the Commercial Real Estate Industry in 201922.1.2019 15:00 | Pressemelding
Automation, use of AI and disintermediating business models having major impact on CRE industry; growing number of CRE firms are directly investing in PropTech companies TORONTO, Jan. 22, 2019 (GLOBE NEWSWIRE) -- Altus Group Limited (“Altus Group”) (TSX: AIF), a leading provider of software, data solutions and independent advisory services to the global commercial real estate (“CRE”) industry, today released the latest Altus Group CRE Innovation Report. The report provides an outlook on technology trends impacting the global CRE industry and highlights the significant acceleration in adoption of property technology (“PropTech”), the effect of disintermediating technologies, as well as a growing trend of CRE firms investing directly in PropTech companies and startups themselves. According to the report, which is based on a global survey of 400 CRE executives at firms with assets under management (“AUM”) of at least US $250 million representing a total AUM of over US $2 trillion, driving
ATTO Technology is Now Certified DataCore Ready™ and will Showcase at the DataCore Partner Conference in Frankfurt, Germany22.1.2019 14:47 | Pressemelding
AMHERST, N.Y., Jan. 22, 2019 (GLOBE NEWSWIRE) -- ATTO Technology, Inc., a global leader of storage, network connectivity and infrastructure solutions for data-intensive computing environments for over 30 years, is proud to announce ATTO Celerity™ Gen 6 32Gb and 16Gb Fibre Channel host bus adapters (HBAs) are certified DataCore Ready™. In addition, as a member of the DataCore Ready Partner Program, ATTO will highlight its certified connectivity options for software-defined storage and data management solutions at the DataCore Partner Conference January 22-23 in Frankfurt, Germany. “We are excited to certify the ATTO Celerity HBAs as DataCore Ready as they will help IT departments achieve the flexibility and freedom that software-defined storage solutions offer, while providing the network performance and reliability that mission-critical applications need,” said Gerardo Dada, CMO of DataCore Software. “We look forward to seeing the products in action at our annual partner conference.” A
PEX Network and iGrafx Release Research Report22.1.2019 14:00 | Pressemelding
Primary Research and Analysis Describes Challenges and Opportunities for Digital Transformation Professionals Orlando, FL, Jan. 22, 2019 (GLOBE NEWSWIRE) -- Today at the OPEX Week: Business Transformation World Summit, PEX Network and iGrafx announced that they completed an extensive primary research project designed to answer the question: “Disrupted or Disruptor – Which Side Are You On?” More than 150 business leaders and digital business transformation experts from 36 industries and 42 countries participated in the survey and provided detailed insights on a range of pressing topics. PEX Networks Editor, Ian Hawkins managed the project and orchestrated analysis and insights from across his organization. “I was frankly surprised and delighted with the breadth and depth of feedback we received from members of the PEX Network community,” said Hawkins. “We now have unprecedented perspective gleaned from respondents on topics like: how to select the right processes to automate, how to mea